Astrana Health, Inc. (ASTH): M&A transaction — Astrana closes Prospect Health acquisition for $708M, updates FY 2025 guidance

Astrana Health, Inc.

Purchase price reduced from $745M to $708M; closed July 1, 2025.
Expects Prospect to contribute ~$1.2B revenue and $81M adjusted EBITDA annually.
Updated FY 2025 guidance: revenue $3.1B-$3.3B, adjusted EBITDA $215M-$225M.
Post-close net debt ~$700M; target net leverage below 2.5x within 12-18 months.
Reiterates Q2 2025 guidance; expects $12M-$15M synergies over 12-18 months.

item 1.01 item 2.01 item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Astrana Health, Inc. completed an acquisition involving PHP Holdings, LLC for $707.9 million in cash and the assumption of certain identified liabilities (closed 2025-07-01).

Action: acquisition
Counterparty: PHP Holdings, LLC
Consideration: $707.9 million in cash and the assumption of certain identified liabilities
Closing: 2025-07-01

Exact text from the filing

intended to address and reconcile post-Closing claims, matters, and obligations between the parties, including a reduction in the aggregate purchase price from $745.0 million to $707.9 million and the removal of certain post-Closing purchase price adjustments and related escrow. The Company and Sellers also entered into certain ancillary agreements, including a

View on SEC.gov

Browse all m&a transactions →

Astrana Health, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-065009

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.